Cowen & Company Initiates Alnylam Pharmaceuticals With Outperform

By: via Benzinga
Cowen & Company initiated coverage on Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) with a Outperform rating, acc. to sources. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.